These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 10193788)

  • 1. Distinction between surmountable and insurmountable selective AT1 receptor antagonists by use of CHO-K1 cells expressing human angiotensin II AT1 receptors.
    Vanderheyden PM; Fierens FL; De Backer JP; Fraeyman N; Vauquelin G
    Br J Pharmacol; 1999 Feb; 126(4):1057-65. PubMed ID: 10193788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between the partially insurmountable antagonist valsartan and human recombinant angiotensin II type 1 receptors.
    Verheijen I; Fierens FL; Debacker JP; Vauquelin G; Vanderheyden PM
    Fundam Clin Pharmacol; 2000; 14(6):577-85. PubMed ID: 11206708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of candesartan on human AT1 receptor-expressing Chinese hamster ovary cells.
    Vauquelin G; Fierens FL; De Backer JP; Vanderheyden PM
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S15-7. PubMed ID: 9892135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A two-state receptor model for the interaction between angiotensin II type 1 receptors and non-peptide antagonists.
    Vauquelin G; Morsing P; Fierens FL; De Backer JP; Vanderheyden PM
    Biochem Pharmacol; 2001 Feb; 61(3):277-84. PubMed ID: 11172731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insurmountable angiotensin AT1 receptor antagonists: the role of tight antagonist binding.
    Fierens FL; Vanderheyden PM; De Backer JP; Vauquelin G
    Eur J Pharmacol; 1999 May; 372(2):199-206. PubMed ID: 10395100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible and syntopic interaction between angiotensin receptor antagonists on Chinese hamster ovary cells expressing human angiotensin II type 1 receptors.
    Vanderheyden PM; Fierens FL; De Backer J; Vauquelin G
    Biochem Pharmacol; 2000 Apr; 59(8):927-35. PubMed ID: 10692557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lys(199) mutation of the human angiotensin type 1 receptor differentially affects the binding of surmountable and insurmountable non-peptide antagonists.
    Fierens FL; Vanderheyden PM; Gáborik Z; Minh TL; Backer JP; Hunyady L; Ijzerman A; Vauquelin G
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):283-8. PubMed ID: 11881039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand binding and functional properties of human angiotensin AT1 receptors in transiently and stably expressed CHO-K1 cells.
    Le MT; De Backer JP; Hunyady L; Vanderheyden PM; Vauquelin G
    Eur J Pharmacol; 2005 Apr; 513(1-2):35-45. PubMed ID: 15878707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonist interaction with endogenous AT(1) receptors in human cell lines.
    Verheijen I; Vanderheyden PM; De Backer JP; Bottari S; Vauquelin G
    Biochem Pharmacol; 2002 Oct; 64(8):1207-14. PubMed ID: 12234601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of angiotensin II-induced inositol phosphate production by triacid nonpeptide antagonists in CHO cells expressing human AT1 receptors.
    Vanderheyden PM; Verheijen I; Fierens FL; DeBacker JP; Vauquelin G
    Pharm Res; 2000 Dec; 17(12):1482-8. PubMed ID: 11303957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II type 1 receptor antagonists. Why do some of them produce insurmountable inhibition?
    Vanderheyden PM; Fierens FL; Vauquelin G
    Biochem Pharmacol; 2000 Dec; 60(11):1557-63. PubMed ID: 11077037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of the antagonist [3H]candesartan to angiotensin II AT1 receptor-transfected [correction of tranfected] Chinese hamster ovary cells.
    Fierens F; Vanderheyden PM; De Backer JP; Vauquelin G
    Eur J Pharmacol; 1999 Feb; 367(2-3):413-22. PubMed ID: 10079018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinctions between non-peptide angiotensin II AT1-receptor antagonists.
    Vauquelin G; Fierens FL; Verheijen I; Vanderheyden PM
    J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1_suppl):S24-S31. PubMed ID: 28095245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide and nonpeptide antagonist interaction with constitutively active human AT1 receptors.
    Le MT; Vanderheyden PM; Szaszák M; Hunyady L; Kersemans V; Vauquelin G
    Biochem Pharmacol; 2003 Apr; 65(8):1329-38. PubMed ID: 12694873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candesartan (CV-11974) dissociates slowly from the angiotensin AT1 receptor.
    Ojima M; Inada Y; Shibouta Y; Wada T; Sanada T; Kubo K; Nishikawa K
    Eur J Pharmacol; 1997 Jan; 319(1):137-46. PubMed ID: 9030909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of KRH-594, an antagonist of the angiotensin II type 1 receptor, to cloned human and rat angiotensin II receptors.
    Inada Y; Nakane T; Chiba S
    Fundam Clin Pharmacol; 2002 Aug; 16(4):317-23. PubMed ID: 12570021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-lasting angiotensin type 1 receptor binding and protection by candesartan: comparison with other biphenyl-tetrazole sartans.
    Vauquelin G; Fierens F; Van Liefde I
    J Hypertens Suppl; 2006 Mar; 24(1):S23-30. PubMed ID: 16601569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of saponin and filipin on antagonist binding to AT 1 receptors in intact cells.
    Verheijen I; Tourlousse D; Vanderheyden PM; Backer JP; Vauquelin G
    Biochem Pharmacol; 2004 Apr; 67(8):1601-6. PubMed ID: 15041477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
    Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
    Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
    Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
    Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.